Cassava Sciences, Inc. (SAVA)
3.265
+0.02
(+0.77%)
USD |
NASDAQ |
Dec 10, 16:00
3.265
0.00 (0.00%)
After-Hours: 16:13
Cassava Sciences Total Assets (Quarterly): 129.73M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.21B |
| Geron Corp. | 567.38M |
| Ovid Therapeutics, Inc. | 63.85M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.16M |
| Shareholders Equity (Quarterly) | 81.57M |
| Current Ratio | 2.267 |